MXCT MaxCyte Inc: Nilai Akuntansi saben Saham

This price action chart for MaxCyte, Inc. (MXCT) illustrates the quotes of a company whose Maryland manufacturing hub ensures system assembly precision through strict climate control. The business dominates the electroporation sector, providing the pricing power to flexibly manage product costs, with the metric currently standing at 1.51. The competitive advantage is further strengthened by high demand from pharma behemoths for consumables used with installed laboratory platforms.

Ekuitas saben Saham MaxCyte Inc. (MXCT): kanggo periode 04.07.2022 - 27.10.2026

Ringkesan rincian data analitis maxcyte.com (MXCT)

- rega lan prakiraan konsensus rega:

Rega saham MaxCyte, Inc|MXCT - Target konsensus

- data kapitalisasi pasar:

Biji pasar MaxCyte, Inc.|MXCT - Total Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham MaxCyte|MXCT - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku maxcyte.com|MXCT - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal MaxCyte, Inc.|MXCT - Utang jangka dawa marang modal|Utang jangka cendhak marang modal MaxCyte|MXCT - Tanggungan utang total perusahaan|Rasio utang marang kapitalisasi buku MaxCyte, Inc.

Pambiji fundamental perusahaan:MaxCyte, Inc.

The integration of ESG standards and the modernization of MaxCyte, Inc. (MXCT) plants to reduce the carbon footprint directly impact the company's tangible asset value. An analysis of the BVPS metric allows for an assessment of the actual equity coverage per share, excluding goodwill distortions, helping investors timely identify write-downs of illiquid positions and avoid acquiring overvalued "paper" capital.

Analisis pesaing MaxCyte, Inc.